Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
Funding Amount
Not stated
Deadline
Forecast — dates not yet posted
Number of Awards
15
Grant Type
Federal
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
From the program guidelines: “The application must clearly indicate the number of Scholar appointments proposed for each year.”
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- School districts
- Public & Indian housing authorities
- Nonprofits (501(c)(3))
- State governments
- Public colleges & universities
- County governments
- Small businesses
- Private colleges & universities
Overview
The National Cancer Institute (NCI) intends to publish a Notice of Funding Opportunity (NOFO), the Paul Calabresi Career Development Award for Clinical Oncology (K12). The NOFO will invite applications for institutional research career development programs to support the training of clinical scientists in cancer research. The purpose of the Paul Calabresi Career Development Award for Clinical Oncology, is to increase the number of clinician-scientists trained in clinical and translational cancer research, promote their career development, and prepare them to be effective scientific partners with basic research scientists. NCI Calabresi K12 programs are required to have at least two oncology specialties represented among the included faculty and the pool of K12 appointees (Scholars). The programs are expected to leverage the institution’s unique strengths in these oncology specialties and to incorporate the latest research and technology advancements in designing cutting-edge career development curricula. And the programs must establish individualized career development plans to accommodate Scholars with different levels of prior research training/experience and assign two mentors, a clinician conducting patient-oriented research and a basic science cancer researcher, to each Scholar. The award budgets may include salary support for the PD(s)/PI(s) and Scholars, research and development support, and administrative support costs. The application must clearly indicate the number of Scholar appointments proposed for each year. Candidates must have a full-time appointment at the applicant institution or a partnering institution. Scholar support is provided for a minimum of two years and a maximum of three years of consecutive funding for each scholar, consisting of 12-month appointments, provided their progress towards an independent academic career is on track and satisfactory. The program will allow the appointment of Scholars proposing to serve as the lead investigato
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: NOT-CA-25-105
- Expected Awards: 15
- Instrument: grant
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Teacher development
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
National Institutes of Health
Amount
Varies
Deadline
October 6, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional). Now let's win it.